Abstract | BACKGROUND:
Epidermal growth factor ( EGF), a potent mitogenic protein, plays an important role in the development of cancers, including glioma. Previous studies showed that the EGF +61G/A polymorphism (rs4444903) may lead to an alteration in EGF production and/or activity, which can result in individual susceptibility to glioma. However, published data regarding the association between the +61G/A polymorphism and glioma risk was contradictory. OBJECTIVE: The aim of this study was to perform a meta-analysis of eligible studies to derive precise estimation of the association of EGF +61G/A with glioma risk. METHODS: We performed a pooled analysis of seven published studies that included 1,613 glioma cases and 2,267 controls. Odds ratios ( ORs) and 95% confidence intervals (CIs) were used to assess the strength of the association. The pooled ORs were performed for codominant model, dominant model, and recessive model, respectively. RESULTS: Overall, no significant associations between the EGF +61G/A polymorphism and glioma cancer risk were found for AA versus GG (OR=0.95, 95% CI=0.62-1.45), GA versus GG (OR=0.94, 95% CI=0.72-1.22), AA/GA versus GG (OR=0.93, 95% CI=0.70-1.23), and AA versus GA/GG (OR=1.04, 95% CI=0.77-1.39). However, in the stratified analysis by ethnicity, the EGF +61G/A polymorphism had a higher risk of glioma development among Asians, but a lower risk among Caucasians. CONCLUSIONS: Taken together, the results suggest that the EGF +61G/A polymorphism may contribute to the susceptibility of glioma in different ethnic groups.
|
Authors | Xin Xu, Lei Xi, Jie Zeng, Qinhong Yao |
Journal | PloS one
(PLoS One)
Vol. 7
Issue 7
Pg. e41470
( 2012)
ISSN: 1932-6203 [Electronic] United States |
PMID | 22829952
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Asian People
(genetics)
- Epidermal Growth Factor
(genetics)
- Female
- Genetic Predisposition to Disease
(genetics)
- Glioma
(genetics)
- Humans
- Male
- Polymorphism, Single Nucleotide
(genetics)
|